Distinct mobility patterns of BRCA2 molecules at DNA damage sites.


Journal

Nucleic acids research
ISSN: 1362-4962
Titre abrégé: Nucleic Acids Res
Pays: England
ID NLM: 0411011

Informations de publication

Date de publication:
02 Jul 2024
Historique:
accepted: 18 06 2024
revised: 10 06 2024
received: 01 12 2023
medline: 2 7 2024
pubmed: 2 7 2024
entrez: 2 7 2024
Statut: aheadofprint

Résumé

BRCA2 is an essential tumor suppressor protein involved in promoting faithful repair of DNA lesions. The activity of BRCA2 needs to be tuned precisely to be active when and where it is needed. Here, we quantified the spatio-temporal dynamics of BRCA2 in living cells using aberration-corrected multifocal microscopy (acMFM). Using multicolor imaging to identify DNA damage sites, we were able to quantify its dynamic motion patterns in the nucleus and at DNA damage sites. While a large fraction of BRCA2 molecules localized near DNA damage sites appear immobile, an additional fraction of molecules exhibits subdiffusive motion, providing a potential mechanism to retain an increased number of molecules at DNA lesions. Super-resolution microscopy revealed inhomogeneous localization of BRCA2 relative to other DNA repair factors at sites of DNA damage. This suggests the presence of multiple nanoscale compartments in the chromatin surrounding the DNA lesion, which could play an important role in the contribution of BRCA2 to the regulation of the repair process.

Identifiants

pubmed: 38953170
pii: 7702506
doi: 10.1093/nar/gkae559
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Journal Cell Science
Organisme : Dutch Cancer Society
Organisme : Erasmus MC, Rotterdam, The Netherlands

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of Nucleic Acids Research.

Auteurs

Maarten W Paul (MW)

Department of Molecular Genetics, Oncode Institute, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.

Jesse Aaron (J)

Advanced Imaging Center, HHMI Janelia, Ashburn VA, USA.

Eric Wait (E)

Advanced Imaging Center, HHMI Janelia, Ashburn VA, USA.
Elephas Biosciences, Madison WI, USA.

Romano M Van Genderen (RM)

Department of Molecular Genetics, Oncode Institute, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.

Arti Tyagi (A)

Department of Molecular Genetics, Oncode Institute, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
Department of Bionanoscience and Kavli Institute of Nanoscience Delft, Delft, University of Technology, Delft, The Netherlands.

Hélène Kabbech (H)

Department of Cell Biology, Erasmus University Medical Center, Rotterdam, The Netherlands.

Ihor Smal (I)

Department of Molecular Genetics, Oncode Institute, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
Theme Biomedical Sciences, Erasmus University Medical Center, Rotterdam, The Netherlands.

Teng-Leong Chew (TL)

Advanced Imaging Center, HHMI Janelia, Ashburn VA, USA.

Roland Kanaar (R)

Department of Molecular Genetics, Oncode Institute, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.

Claire Wyman (C)

Department of Molecular Genetics, Oncode Institute, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
Department of Radiation Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.

Classifications MeSH